| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |